Exelixis
EXEL
413 hedge funds and large institutions have $5.47B invested in Exelixis in 2024 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 140 increasing their positions, 173 reducing their positions, and 44 closing their positions.
101% more call options, than puts
Call options by funds: $62.5M | Put options by funds: $31M
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
0.08% less ownership
Funds ownership: 83.68% → 83.6% (-0.08%)
5% less first-time investments, than exits
New positions opened: 42 | Existing positions closed: 44
2% less funds holding
Funds holding: 422 → 413 (-9)
9% less capital invested
Capital invested by funds: $6.02B → $5.47B (-$547M)
19% less repeat investments, than reductions
Existing positions increased: 140 | Existing positions reduced: 173
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSV Asset Management
Chicago,
Illinois
|
+$66.3M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$17.2M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$10.3M |
| 4 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$10.2M |
| 5 |
CP
Caligan Partners
New York
|
+$9.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$53.5M |
| 2 |
Los Angeles Capital Management
Los Angeles,
California
|
-$36.7M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$30.8M |
| 4 |
BlackRock
New York
|
-$30.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$25.9M |
EXEL Hedge Fund Activity: Q2 2024 in Review
413 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q2 2024, worth a combined $5.47B — down 9.1% from $6.02B a quarter earlier.
Sellers outnumbered buyers: 44 funds closed out of EXEL and 42 opened new positions — a net loss of 2 holders — while 173 trimmed existing stakes and 140 added.
The largest buyer was LSV Asset Management, adding an estimated $66.3M. The largest seller was Morgan Stanley, cutting an estimated $53.5M.
- 413 institutional investors held Exelixis (EXEL) as of Q2 2024, down from 422 in Q1 2024.
- Funds reported $5.47B of Exelixis stock for Q2 2024, down 9.1% quarter-over-quarter.
- 42 funds opened new Exelixis positions in Q2 2024 and 44 closed out, a net change of -2 holders.
- The largest Exelixis buyer in Q2 2024 was LSV Asset Management, an estimated $66.3M added.
- The largest Exelixis seller in Q2 2024 was Morgan Stanley, an estimated $53.5M sold.
Based on aggregated 13F filings for Q2 2024.